Trials / Conditions / Optic Neuropathy, Ischemic

Optic Neuropathy, Ischemic

6 registered clinical trials studyying Optic Neuropathy, Ischemic — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Optic Nerve Sheath Ultrasound in Giant Cell Arteritis NCT05749094	Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal	—
Completed	Building Research With Artificial Intelligence in Neuro-Ophthalmology NCT06390579	Fondation Ophtalmologique Adolphe de Rothschild	—
Unknown	Retrobulbar Triamcinolone Acetonide Injection in the Treatment of NA-AION NCT02329288	Second Military Medical University	Phase 3
Withdrawn	Treatment Study for Ischemic Optic Neuropathy With Opthalmic Timolol Maleate 0.5% NCT01607671	Fraser Health	Phase 1
Completed	A Study to Assess Whether PDE5 Inhibitors Increase the Chance of Triggering the Onset of Acute NAION NCT00759174	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	—
Completed	Neural Conduction Along the Visual Pathways After Oral Treatment With Citicoline in Patients With Optic Nerve NCT00404729	Fondazione G.B. Bietti, IRCCS	Phase 4